Related Experiment Video
Updated: Sep 6, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Protocol for a systematic review on routine use of antibiotics for infants less than 6 months of age with growth
Aamer Imdad1, Fanny F Chen2, Melissa François2
1Division of Pediatric Gastroenterology, Department of Pediatrics, SUNY Upstate Medical University, Syracuse, New York, USA imdada@upstate.edu.
Insights
This systematic review examines antibiotic effectiveness for infants under six months experiencing growth faltering. Evidence is limited, highlighting the need for better treatment guidelines for this vulnerable population.
Area of Science:
- Pediatrics
- Infectious Diseases
- Public Health
Background:
- Antibiotics are used for severe acute malnutrition in children (6-59 months).
- Data on antibiotic use for infants under six months with growth failure is scarce.
- The World Health Organization (WHO) is developing guidelines for infant wasting and growth faltering.
Purpose of the Study:
- To systematically review and synthesize current evidence on antibiotic effectiveness in treating infants under six months with growth failure/faltering.
- To inform WHO guideline development for preventing and treating wasting in young infants.
- To address the lack of data for this specific age group.
Main Methods:
- Systematic review and meta-analysis of randomized controlled trials and non-randomized studies with a control arm.
- Searches across multiple electronic databases.
- Inclusion criteria: infants < 6 months with growth failure; intervention: no/alternative antibiotics; comparison: WHO 2013 guideline antibiotics.
- Outcomes include mortality, clinical deterioration, antimicrobial resistance, and adverse events.
Main Results:
- The review synthesizes evidence from eligible studies.
- Meta-analysis will be used to pool data where applicable.
- Evidence quality will be assessed using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach.
Conclusions:
- Findings will be published in a peer-review journal.
- The review will guide WHO recommendations on antibiotic use in infants < 6 months with growth failure.
- This research addresses a critical knowledge gap in pediatric nutrition and infectious disease management.
Introduction:
Antibiotics have been used as an adjunct in treating children with severe acute malnutrition 6-59 months of age; however, the data for infants less than 6 months are scarce. The WHO recently started guideline development for preventing and treating wasting, including growth failure/faltering in infants less than 6 months. This systematic review commissioned by WHO aims to synthesise evidence from current literature on the effectiveness of antibiotics for infants less than 6 months of age with growth failure/faltering.
Methods And Analysis:
We will conduct a systematic review and meta-analysis for studies that assessed the effect of antibiotics in the treatment of infants with growth faltering. We will search multiple electronic databases. We will include randomised control trials and non-randomised studies with a control arm. The study population is infants less than 6 months of age with growth failure. The intervention group will be infants who received no antibiotics or antibiotics other than recommended in 2013 guidelines by WHO to treat severe acute malnutrition in children. The comparison group will be infants who received antibiotics according to the 2013 guideline by WHO. We will consider the following outcomes: mortality, clinical deterioration, antimicrobial resistance, recovery from comorbidity, adverse events, markers of intestinal inflammation, markers of systemic inflammation, hospital-acquired infections, non-response. We will use the meta-analysis to pool the studies where applicable. We will use the Grading of Recommendations Assessment, Development, and Evaluation approach to reporting the overall evidence quality for an outcome.
Ethics And Dissemination:
This is a systematic review and will not involve contact with a human subject. The findings of this review will be published in a peer-review journal and will guide the WHO's recommendation for the use of antibiotics in infants less than 6 months of age with growth failure.
Prospero Registration Number:
CRD42021277073.
Related Concept Videos
Antibiotic Selection
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Regulation
Antimicrobial Effectiveness
Development of Antibiotic Resistance

